Given the early onset of the dementia syndrome, the patient and her family expressed interest in pursuing a study with AD biomarkers in the CSF, which revealed low levels of beta-amyloid, high levels of total tau and phosphotau, a pattern suggestive of CBS with evidence of AD pathology. The gene discussed is MAPT; the disease is Alzheimer disease.